You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a 70-year old woman with a prior history of ...
The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...
Baptist Heart & Vascular Institute cardiologists, advanced practice providers and BHVI leadership recently gathered to celebrate the performance of its 1,000th Watchman procedure. The procedure is a ...
LAKE CHARLES, La. (KPLC) - A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have implanted 500 Watchman devices for patients with ...
Marian Regional Medical Center has successfully completed its 500th Watchman procedure, a milestone in providing advanced treatment options for patients with atrial fibrillation (AFib). The Watchman ...
DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take Eliquis ...
The OPTION trial showed equivalence between Watchman FLX and oral anticoagulation in preventing stroke, systemic embolism, and all-cause death post-ablation. Subgroup analyses revealed consistent ...
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...
MedStar Heart & Vascular Institute now offers patients with irregular heart rhythm a minimally invasive option to reduce the risk of stroke, as well as enable stopping long-term use of blood thinning ...
Medicare covers the Watchman procedure for eligible beneficiaries with nonvalvular AFib. To qualify for Medicare coverage, people must meet specific criteria, including having nonvalvular AFib, being ...
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17. In late-breaking data presentations, the ADVANTAGE AF trial for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback